FI973023L - Liikakasvusairauksien yhdistetty terapeuttinen hoito - Google Patents

Liikakasvusairauksien yhdistetty terapeuttinen hoito Download PDF

Info

Publication number
FI973023L
FI973023L FI973023A FI973023A FI973023L FI 973023 L FI973023 L FI 973023L FI 973023 A FI973023 A FI 973023A FI 973023 A FI973023 A FI 973023A FI 973023 L FI973023 L FI 973023L
Authority
FI
Finland
Prior art keywords
therapeutic treatment
combined therapeutic
hypertrophic disorders
hypertrophic
disorders
Prior art date
Application number
FI973023A
Other languages
English (en)
Swedish (sv)
Other versions
FI973023A0 (fi
FI119911B (fi
Inventor
Bruno Tocque
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of FI973023L publication Critical patent/FI973023L/fi
Publication of FI973023A0 publication Critical patent/FI973023A0/fi
Application granted granted Critical
Publication of FI119911B publication Critical patent/FI119911B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI973023A 1995-01-17 1997-07-16 Liikakasvusairauksien yhdistetty terapeuttinen hoito FI119911B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR9500436A FR2729295A1 (fr) 1995-01-17 1995-01-17 Traitement therapeutique combine des pathologies hyperproliferatives
FR9500436 1995-01-17
FR9600056 1996-01-12
PCT/FR1996/000056 WO1996022101A1 (fr) 1995-01-17 1996-01-12 Traitement therapeutique combine des pathologies hyperproliferatives

Publications (3)

Publication Number Publication Date
FI973023L true FI973023L (fi) 1997-07-16
FI973023A0 FI973023A0 (fi) 1997-07-16
FI119911B FI119911B (fi) 2009-05-15

Family

ID=9475169

Family Applications (1)

Application Number Title Priority Date Filing Date
FI973023A FI119911B (fi) 1995-01-17 1997-07-16 Liikakasvusairauksien yhdistetty terapeuttinen hoito

Country Status (21)

Country Link
US (3) US6262032B1 (fi)
EP (1) EP0800399B1 (fi)
JP (3) JP4580469B2 (fi)
KR (1) KR100385266B1 (fi)
AT (1) ATE222109T1 (fi)
AU (1) AU716364B2 (fi)
BR (1) BR9606969A (fi)
CA (1) CA2209771C (fi)
CZ (1) CZ298710B6 (fi)
DE (1) DE69622989T2 (fi)
DK (1) DK0800399T3 (fi)
ES (1) ES2180729T3 (fi)
FI (1) FI119911B (fi)
FR (1) FR2729295A1 (fi)
HU (1) HU229484B1 (fi)
MX (1) MX9704490A (fi)
NO (1) NO325418B1 (fi)
PT (1) PT800399E (fi)
SI (1) SI0800399T1 (fi)
SK (1) SK283989B6 (fi)
WO (1) WO1996022101A1 (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030044396A1 (en) * 1998-04-21 2003-03-06 Elia James P. Methods for treating diseases and increasing longevity
FR2729295A1 (fr) * 1995-01-17 1996-07-19 Rhone Poulenc Rorer Sa Traitement therapeutique combine des pathologies hyperproliferatives
US7087582B1 (en) 1995-09-26 2006-08-08 Regents Of The University Of Michigan Combination for site-specifically transforming cells in vivo comprising a double-balloon catheter and nucleic acid comprising a gene encoding P21
US5744460A (en) * 1996-03-07 1998-04-28 Novartis Corporation Combination for treatment of proliferative diseases
US20030064949A1 (en) * 1998-02-17 2003-04-03 Loretta Nielsen Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
US20030060434A1 (en) * 1997-02-18 2003-03-27 Loretta Nielsen Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
DE60203260T2 (de) 2001-01-16 2006-02-02 Glaxo Group Ltd., Greenford Pharmazeutische kombination, die ein 4-chinazolinamin und paclitaxel, carboplatin oder vinorelbin enthält, zur behandlung von krebs
BRPI0411485A (pt) * 2003-06-30 2006-07-25 Univ Lausanne peptìdeo derivado de rasgap para matar seletivamente células cancerosas
JPWO2005061007A1 (ja) * 2003-12-24 2007-07-12 学校法人 聖マリアンナ医科大学 癌の抑制方法
KR100809890B1 (ko) * 2003-12-24 2008-03-06 가부시키가이샤 로코모젠 암 억제 방법
GB0406415D0 (en) * 2004-03-22 2004-04-21 Inst Of Cancer Res The Materials and methods for treatment of cancer
US8124598B2 (en) 2006-09-14 2012-02-28 Sharon Sageman 7-keto DHEA for psychiatric use
WO2008115478A2 (en) * 2007-03-19 2008-09-25 University Of Medicine And Dentistry Of New Jersey Method of cancer detection and treatment
US20100160274A1 (en) * 2007-09-07 2010-06-24 Sharon Sageman 7-KETO DHEA for Psychiatric Use

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE122727T1 (de) * 1986-03-28 1995-06-15 Univ Illinois Zubereitungen und verfahren für klone, die, mit mehrfacharzneimittelresistenz assoziierte, dna- sequenzen in menschlichen zellen enthalten.
US6410010B1 (en) * 1992-10-13 2002-06-25 Board Of Regents, The University Of Texas System Recombinant P53 adenovirus compositions
US5747469A (en) 1991-03-06 1998-05-05 Board Of Regents, The University Of Texas System Methods and compositions comprising DNA damaging agents and p53
CA2136091A1 (en) * 1992-05-20 1993-11-25 Daniel S. Martin Chemotherapeutic drug combinations
JPH07507776A (ja) * 1992-05-28 1995-08-31 ゼノバ　リミテッド 癌の治療法
FR2694296B1 (fr) * 1992-07-30 1994-09-02 Rhone Poulenc Rorer Sa Peptides inhibant l'activité des protéines ras, préparation et utilisation.
CA2144848A1 (en) * 1992-09-18 1994-03-31 H. Michael Shepard Gene therapy by retroviral vector with tumor suppressive gene
FR2697752B1 (fr) * 1992-11-10 1995-04-14 Rhone Poulenc Rorer Sa Compositions antitumorales contenant des dérivés du taxane.
TW442569B (en) 1993-10-25 2001-06-23 Canji Inc Recombinant adenoviral vector
FR2729295A1 (fr) * 1995-01-17 1996-07-19 Rhone Poulenc Rorer Sa Traitement therapeutique combine des pathologies hyperproliferatives
US5789244A (en) 1996-01-08 1998-08-04 Canji, Inc. Compositions and methods for the treatment of cancer using recombinant viral vector delivery systems
US6054467A (en) 1996-07-05 2000-04-25 Sidney Kimmel Cancer Center Down-regulation of DNA repair to enhance sensitivity to P53-mediated apoptosis

Also Published As

Publication number Publication date
DE69622989D1 (de) 2002-09-19
ATE222109T1 (de) 2002-08-15
SK95797A3 (en) 1997-12-10
US7884082B2 (en) 2011-02-08
WO1996022101A1 (fr) 1996-07-25
CZ226297A3 (en) 1997-10-15
SK283989B6 (sk) 2004-07-07
JP2012036201A (ja) 2012-02-23
BR9606969A (pt) 1997-11-04
DE69622989T2 (de) 2002-12-05
NO973197D0 (no) 1997-07-09
JP4580469B2 (ja) 2010-11-10
US6262032B1 (en) 2001-07-17
EP0800399B1 (fr) 2002-08-14
CZ298710B6 (cs) 2008-01-02
PT800399E (pt) 2002-12-31
SI0800399T1 (en) 2002-12-31
JP2008133291A (ja) 2008-06-12
CA2209771C (fr) 2012-01-03
KR19980701449A (ko) 1998-05-15
US20010021395A1 (en) 2001-09-13
HU229484B1 (en) 2014-01-28
FI973023A0 (fi) 1997-07-16
US20040127437A1 (en) 2004-07-01
AU716364B2 (en) 2000-02-24
JP5031921B2 (ja) 2012-09-26
NO973197L (no) 1997-07-09
AU4542996A (en) 1996-08-07
EP0800399A1 (fr) 1997-10-15
US20050209177A9 (en) 2005-09-22
CA2209771A1 (fr) 1996-07-25
HUP9802423A3 (en) 2000-11-28
ES2180729T3 (es) 2003-02-16
JPH10512559A (ja) 1998-12-02
FR2729295A1 (fr) 1996-07-19
MX9704490A (es) 1997-10-31
HUP9802423A2 (hu) 1999-02-01
DK0800399T3 (da) 2002-12-02
NO325418B1 (no) 2008-04-21
FR2729295B1 (fi) 1997-02-28
FI119911B (fi) 2009-05-15
KR100385266B1 (ko) 2005-09-07

Similar Documents

Publication Publication Date Title
NO982172D0 (no) Anvendelse av epinastin for behandling av smerter
EP0925046A4 (en) TOPICAL PREPARATIONS AND METHODS FOR TREATING HEMORRHOIDS
FI973292A7 (fi) Substituoituja isoksatsoleja tulehduksen hoitamiseksi
DE69622993D1 (de) Sanft behandeltes ungekrepptes durchblasgetrocknetes tissue
FI973023L (fi) Liikakasvusairauksien yhdistetty terapeuttinen hoito
DE69620691D1 (de) Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
NO995231D0 (no) Terapeutisk behandling av hudlidelser
IL119459A0 (en) Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases
NO973081D0 (no) Fremgangmåte for behandling av kroniske progressive vaskulære sykdommer
NO973531D0 (no) Anvendelse av melatonin for behandling av pasienter som lider av medikamentavhengighet
EE9700235A (et) Benseenamiidid neurodegeneratiivsete haiguste ravimiseks
NO982562D0 (no) Sammensetning for behandling av smerte
NO981822L (no) Anvendelse av proteinet GAX for behandling av cancer
NO973366D0 (no) Fremgangsmåte for behandling av multippel sklerose
EP0800396A4 (en) TREATMENT OF HYPERANDROGEN STATES
IL131347A0 (en) Treatment of skin disorders
ID24922A (id) Terapi kombinasi untuk pengobatan aids
FI952953A7 (fi) Aineita metabolisten luustosairauksien hoitamiseen
DE69522685D1 (de) Behandlung von blut-plasma
FR2755008B3 (fr) Pomme de douche pour massage et therapie
HUP0000124A3 (en) Uridine-comprising therapeutic active agent for treatment of neurodegenerative disorders
KR970004278U (ko) 마사지용 지압구
DK236489D0 (da) Anvendelse af diazepinoner til terapeutisk behandling af mikrokredsloebsforstyrrelser
ID24439A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
HU9500304V0 (en) Therapeutic aid for treatment of foot

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 119911

Country of ref document: FI

MA Patent expired